Yuji Hirowatari

1.1k total citations
51 papers, 840 citations indexed

About

Yuji Hirowatari is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Yuji Hirowatari has authored 51 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 22 papers in Endocrinology, Diabetes and Metabolism and 14 papers in Molecular Biology. Recurrent topics in Yuji Hirowatari's work include Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers) and Cancer, Lipids, and Metabolism (11 papers). Yuji Hirowatari is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (14 papers) and Cancer, Lipids, and Metabolism (11 papers). Yuji Hirowatari collaborates with scholars based in Japan and United States. Yuji Hirowatari's co-authors include Hiroshi Yoshida, Hideo Kurosawa, Katsuko Hara, Hakuo Takahashi, Hidekatsu Yanai, Norio Tada, Shoji Usami, Kohtaro Kirimura, Kumie Ito and Masamichi Yoshika and has published in prestigious journals such as American Journal of Clinical Nutrition, Analytical Biochemistry and Scientific Reports.

In The Last Decade

Yuji Hirowatari

51 papers receiving 816 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuji Hirowatari Japan	18	268	233	215	139	138	51	840
Szilvia Török Hungary	17	330 1.2×	146 0.6×	111 0.5×	125 0.9×	90 0.7×	43	917
Gergő Szűcs Hungary	18	341 1.3×	160 0.7×	136 0.6×	188 1.4×	222 1.6×	32	1.0k
Lina Nordquist Sweden	19	349 1.3×	209 0.9×	163 0.8×	196 1.4×	85 0.6×	34	1.2k
Urna Kansakar United States	20	440 1.6×	157 0.7×	196 0.9×	159 1.1×	260 1.9×	53	1.1k
Hiroya Hidaka Japan	20	410 1.5×	245 1.1×	143 0.7×	392 2.8×	94 0.7×	51	977
Ruihai Zhou United States	17	337 1.3×	172 0.7×	71 0.3×	96 0.7×	133 1.0×	40	904
Tomoyuki Honjo Japan	17	218 0.8×	203 0.9×	129 0.6×	172 1.2×	252 1.8×	31	983
Isra Marei Qatar	12	336 1.3×	134 0.6×	131 0.6×	172 1.2×	95 0.7×	23	805
Limei Liu China	23	621 2.3×	180 0.8×	288 1.3×	317 2.3×	199 1.4×	69	1.5k
Francesc Jiménez‐Altayó Spain	21	376 1.4×	124 0.5×	113 0.5×	257 1.8×	214 1.6×	59	1.2k

Countries citing papers authored by Yuji Hirowatari

Since Specialization

Citations

This map shows the geographic impact of Yuji Hirowatari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Hirowatari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Hirowatari more than expected).

Fields of papers citing papers by Yuji Hirowatari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Hirowatari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Hirowatari. The network helps show where Yuji Hirowatari may publish in the future.

Co-authorship network of co-authors of Yuji Hirowatari

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Hirowatari. A scholar is included among the top collaborators of Yuji Hirowatari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Hirowatari. Yuji Hirowatari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yoshida, Hiroshi, et al.. (2021). Clinical Significance of Intermediate-Density Lipoprotein Cholesterol Determination as a Predictor for Coronary Heart Disease Risk in Middle-Aged Men. Frontiers in Cardiovascular Medicine. 8. 756057–756057. 10 indexed citations

Oda, Hitomi, Akihiro Mori, Yuji Hirowatari, et al.. (2017). Cholesterol concentrations in lipoprotein fractions separated by anion-exchange–high-performance liquid chromatography in healthy dogs and dogs with hypercholesterolemia. Research in Veterinary Science. 114. 163–169. 7 indexed citations

Takahashi, Jun, Ryuji Tsuburaya, Kensuke Nishimiya, et al.. (2016). Plasma concentration of serotonin is a novel biomarker for coronary microvascular dysfunction in patients with suspected angina and unobstructive coronary arteries. European Heart Journal. 38(7). ehw448–ehw448. 55 indexed citations

Yanai, Hidekatsu, Yuji Hirowatari, Kumie Ito, et al.. (2016). Understanding of Diabetic Dyslipidemia by Using the Anion-Exchange High Performance Liquid Chromatography Data. Journal of Clinical Medicine Research. 8(5). 424–426. 13 indexed citations

Kurano, Makoto, Tomotaka Dohi, T. Kobayashi, et al.. (2015). Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids. PubMed. 4. 92–98. 30 indexed citations

Ito, Kumie, Hiroshi Yoshida, Hidekatsu Yanai, et al.. (2013). Relevance of intermediate-density lipoprotein cholesterol to Framingham risk score of coronary heart disease in middle-aged men with increased non-HDL cholesterol. International Journal of Cardiology. 168(4). 3853–3858. 23 indexed citations

Yoshida, Hiroshi, Yuji Hirowatari, Hideo Kurosawa, et al.. (2012). Estimation of lipoprotein profile in patients with type II diabetes and its relevance to remnant lipoprotein cholesterol levels. Atherosclerosis. 222(2). 541–544. 12 indexed citations

Yanai, Hidekatsu, et al.. (2011). Effects of Liraglutide, a Human Glucagon-Like Peptide-1 Analog, on Glucose/Lipid Metabolism, and Adipocytokines in Patients With Type 2 Diabetes. Journal of Endocrinology and Metabolism. 1(3). 149–151. 8 indexed citations

Hara, Katsuko, et al.. (2011). Serotonin levels in platelet-poor plasma and whole blood in people with type 2 diabetes with chronic kidney disease. Diabetes Research and Clinical Practice. 94(2). 167–171. 46 indexed citations

10.

Hirowatari, Yuji, et al.. (2011). Serotonin Levels in Platelet-Poor Plasma and Whole Blood from Healthy Subjects: Relationship with Lipid Markers and Coronary Heart Disease Risk Score. Journal of Atherosclerosis and Thrombosis. 18(10). 874–882. 23 indexed citations

11.

Tamura, Shogo, Hidenori Suzuki, Yuji Hirowatari, et al.. (2011). Release reaction of brain-derived neurotrophic factor (BDNF) through PAR1 activation and its two distinct pools in human platelets. Thrombosis Research. 128(5). e55–e61. 51 indexed citations

12.

Yoshida, Hiroshi, Toshitsugu Ishikawa, Hideo Kurosawa, et al.. (2010). Effects of Supervised Aerobic Exercise Training on Serum Adiponectin and Parameters of Lipid and Glucose Metabolism in Subjects with Moderate Dyslipidemia. Journal of Atherosclerosis and Thrombosis. 17(11). 1160–1166. 38 indexed citations

13.

Hirowatari, Yuji, et al.. (2009). Analysis of cholesterol levels in lipoprotein(a) with anion-exchange chromatography. Journal of Lipid Research. 51(5). 1237–1243. 13 indexed citations

14.

Yoshida, Hiroshi, Hideo Kurosawa, Yuji Hirowatari, et al.. (2008). Characteristic comparison of triglyceride-rich remnant lipoprotein measurement between a new homogenous assay (RemL-C) and a conventional immunoseparation method (RLP-C). Lipids in Health and Disease. 7(1). 18–18. 17 indexed citations

15.

Kurosawa, Hideo, Hiroshi Yoshida, Hidekatsu Yanai, et al.. (2007). Comparative study between anion-exchange HPLC and homogeneous assay methods in regard to the accuracy of high- and low-density lipoprotein cholesterol measurement. Clinical Biochemistry. 40(16-17). 1291–1296. 8 indexed citations

16.

Ohkawa, Ryunosuke, Yuji Hirowatari, Kazuhiro Nakamura, et al.. (2005). Platelet release of β-thromboglobulin and platelet factor 4 and serotonin in plasma samples. Clinical Biochemistry. 38(11). 1023–1026. 33 indexed citations

17.

Yoshida, Hiroshi, Kayoko Sasaki, Yuji Hirowatari, et al.. (2004). Increased serum iron may contribute to enhanced oxidation of low-density lipoprotein in smokers in part through changes in lipoxygenase and catalase. Clinica Chimica Acta. 345(1-2). 161–170. 19 indexed citations

18.

Hirowatari, Yuji, Katsuko Hara, Hiroshi Kamihata, Toshiji Iwasaka, & Hakuo Takahashi. (2003). High-performance liquid chromatographic method with column-switching and post-column reaction for determination of serotonin levels in platelet-poor plasma. Clinical Biochemistry. 37(3). 191–197. 34 indexed citations

19.

Hirowatari, Yuji, et al.. (2003). Measurement of cholesterol of major serum lipoprotein classes by anion-exchange HPLC with perchlorate ion-containing eluent. Journal of Lipid Research. 44(7). 1404–1412. 53 indexed citations

20.

Hirowatari, Yuji, et al.. (2002). Analysis method for lipoproteins by high-performance liquid chromatography with sulfopropyl-ligand column and magnesium ion-containing eluents. Analytical Biochemistry. 308(2). 336–342. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact